Ambeed.cn

首页 / / / 脱氢酶 / (R)-GNE-140

(R)-GNE-140 {[allProObj[0].p_purity_real_show]}

货号:A932685

(R)-GNE-140 is a potent lactate dehydrogenase A (LDHA) inhibitor with IC50s of 3 nM and 5 nM for LDHA and LDHB respectively.

(R)-GNE-140 化学结构 CAS号:2003234-63-5
(R)-GNE-140 化学结构
CAS号:2003234-63-5
(R)-GNE-140 3D分子结构
CAS号:2003234-63-5
(R)-GNE-140 化学结构 CAS号:2003234-63-5
(R)-GNE-140 3D分子结构 CAS号:2003234-63-5
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

(R)-GNE-140 纯度/质量文件 产品仅供科研

货号:A932685 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nat. Biomed. Eng., 2024, 8, 1412-1424. Ambeed. [ A538667 , A631746 ]
JMC, 2024. Ambeed. [ A833302 , A475501 , A341986 , A356070 ]
BMC Cancer, 2024, 24(1): 1415. Ambeed. [ A809692 , A209020 ]
J. Am. Soc. Mass Spectrom., 2024, 35(12): 3192-3202. Ambeed. [ A166127 , A902473 , A753371 , A961334 , A292945 , A230770 , A300620 , A1114580 , A1159765 , A206238 ]
PloS One, 2024, 19(11): e0308060. Ambeed. [ A302917 ]
更多 >
产品名称 Dehydrogenase 其他靶点 纯度
Trilostane 99+%
AGI-6780 +++

IDH2 R140Q mutant, IC50: 23 nM

99%+
Gimeracil 98%
AGI-5198 ++

R132H-IDH1, IC50: 70 nM

R132C-IDH1, IC50: 0.16 μM

99%+
SW033291 ++++

15-PGDH, IC50: 1.5 nM

15-PGDH, Ki: 0.1 nM

99%+
Mycophenolic acid 99+%
Fomepizole 98%
Leflunomide 98%
3-Nitropropanoic acid 99%+
Isovaleramide 98%
Mycophenolate Mofetil +++

Inosine monophosphate dehydrogenase I, IC50: 39 nM

Inosine monophosphate dehydrogenase II, IC50: 27 nM

98%
MK-8245 ++++

SCD1 (rat), IC50: 3 nM

SCD1 (mouse), IC50: 1 nM

99%+
Vidofludimus ++

Human DHODH, IC50: 134 nM

99%+
Emodin 98%
Ivosidenib 98%
NCT-501 ++

ALDH1A1, IC50: 40 nM

98%
Gossypol 99%+
Devimistat 98%
Disulfiram 98%+
Enasidenib ++++

IDH2, IC50: 12 nM

98%
PluriSIn 1 99%+
ML390 +

DHODH, IC50: 0.56 μM

99%+
Teriflunomide 99%+
Daidzin +++

ALDH-Ⅰ, Ki: 20 nM

98+%
18β-Glycyrrhetinic acid 99%
RRx-001 95%
NCT-503 +

PHGDH, IC50: 2.5 μM

99%+
Vorasidenib 99%+
Ammonium Glycyrrhizinate(x:1) 98+%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

(R)-GNE-140 生物活性

描述 In the lactate dehydrogenase (LDH) family, Lactate dehydrogenase A (LDHA) is the enzyme that catalyzes the conversion of L-lactate and NAD to pyruvate and NADH in the final step of anaerobic glycolysis. Another isoform, Lactate dehydrogenase B (LDHB) catalyzes the interconversion of pyruvate and lactate with concomitant interconversion of NADH and NAD+ in a post-glycolysis process. As altered glycolytic metabolism is a feature of cancer cells, inhibition of LDHA and LDHB, thus reducing glycolysis was assumed to have anti-tumor potential. R)-GNE-140 is an LDH inhibitor. Based on enzymatic assays, the inhibitory IC50 values of (R)-GNE-140 against LDHA and LDHB are 3 nM and 5 nM, respectively. Results of a lactate production assay in pancreatic MiaPaca2 cell line shows that (R)-GNE-140 inhibited lactate production with the IC­50 of 0.67 μM[2]. In an experiment to determine the IC50s of (R)-GNE-140 across a panel of pancreatic cell lines, it was reported that the 4 cell lines of MiaPaca2, KP2, PSN1 and Hup-T3 are sensitive to (R)-GNE-140 with IC50s below 5 μM. When MiaPaca-2 cells were incubated with 2 μM (R)-GNE-140 for the 1 - 5 days and then assessed for levels of active caspase-3 or sub-2N content, levels of active caspase-3 increased within 1 - 2 d and peaked at around days 2 - 3, while obvious increase in cell death (appearance of cells with a DNA content <2N) was first detected at day 3[3]. In xenograft studies, (R)-GNE-140 was administrated to MiaPaca-2-tumor-bearing mice twice daily at 100, 200, and 400 mg/kg for a total of 7 days. A dose-dependent significant reduction in lactate levels and a corresponding increase in both pyruvate and glycerol-3-phosphate levels was observed within 1h of the last GNE-140 dose but not 6h after the last dose, suggesting rapid clearance of GNE-140 in vivo. Consequently, tumor-bearing mice treated for 21 d with twice daily administration of 100, 200 and 400 mg/kg GNE-140 showed no tumor growth inhibition when compared to vehicle control animals[3].
作用机制 X-ray structure assay revealed that GNE-140 bound to LDHA by forming hydrogen bonds in the active site adjacent to NADH[3].

(R)-GNE-140 动物研究

Dose Mice: 5 mg/kg - 200 mg/kg[1] (p.o.); 1 mg/kg[1] (i.v.)
Administration p.o., i.v.
Pharmacokinetics
Animal Mice[1]
Dose 1 mg/kg (i.v.)
5 mg/kg (p.o.)
Administration i.v.
p.o.
F 70% (p.o.)
T1/2 1.0 h (i.v.)
AUC 1.5 μM·h (i.v.)
5.1 μM·h (p.o.)
CLp 21.1 ml/min/kg (i.v.)
Cmax 2.5 μM (i.v.)
1.7 μM (p.o.)
Vss 1.4 L/kg (i.v.)

(R)-GNE-140 参考文献

[1]Purkey HE, Robarge K, et al. Cell Active Hydroxylactam Inhibitors of Human Lactate Dehydrogenase with Oral Bioavailability in Mice. ACS Med Chem Lett. 2016 Aug 26;7(10):896-901. eCollection 2016 Oct 13.

[2]Purkey HE, Robarge K, Chen J, Chen Z, Corson LB, Ding CZ, DiPasquale AG, Dragovich PS, Eigenbrot C, Evangelista M, Fauber BP, Gao Z, Ge H, Hitz A, Ho Q, Labadie SS, Lai KW, Liu W, Liu Y, Li C, Ma S, Malek S, O'Brien T, Pang J, Peterson D, Salphati L, Sideris S, Ultsch M, Wei B, Yen I, Yue Q, Zhang H, Zhou A. Cell Active Hydroxylactam Inhibitors of Human Lactate Dehydrogenase with Oral Bioavailability in Mice. ACS Med Chem Lett. 2016 Aug 26;7(10):896-901.

[3]Boudreau A, Purkey HE, Hitz A, Robarge K, Peterson D, Labadie S, Kwong M, Hong R, Gao M, Del Nagro C, Pusapati R, Ma S, Salphati L, Pang J, Zhou A, Lai T, Li Y, Chen Z, Wei B, Yen I, Sideris S, McCleland M, Firestein R, Corson L, Vanderbilt A, Williams S, Daemen A, Belvin M, Eigenbrot C, Jackson PK, Malek S, Hatzivassiliou G, Sampath D, Evangelista M, O'Brien T. Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition. Nat Chem Biol. 2016 Oct;12(10):779-86.

(R)-GNE-140 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.00mL

0.40mL

0.20mL

10.02mL

2.00mL

1.00mL

20.04mL

4.01mL

2.00mL

(R)-GNE-140 技术信息

CAS号2003234-63-5
分子式C25H23ClN2O3S2
分子量 499.045
别名
运输蓝冰
存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Keep in dark place,Sealed in dry,2-8°C

溶解度

DMSO: 50 mg/mL(100.19 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。